IDEXX Laboratories, Inc. (IDXX)
NASDAQ · Healthcare
IDEXX Laboratories, Inc. Income Statement 2008–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenue | 4.30B | 3.90B | 3.66B | 3.37B | 3.22B | 2.71B | 2.41B | 2.21B | 1.97B | 1.78B | 1.60B | 1.49B | 1.38B | 1.29B | 1.22B | 1.10B | 1.03B | 1.02B |
| Gross Profit | 2.66B | 2.38B | 2.19B | 2.00B | 1.89B | 1.57B | 1.37B | 1.24B | 1.10B | 975.4M | 890.3M | 816.1M | 756.1M | 699.1M | 646.5M | 578.6M | 526.3M | 529.8M |
| Profitability | ||||||||||||||||||
| Operating Income | 1.36B | 1.13B | 1.10B | 898.8M | 932.0M | 694.5M | 552.8M | 491.3M | 413.0M | 350.2M | 299.9M | 260.3M | 266.8M | 262.6M | 236.2M | 203.9M | 176.0M | 172.5M |
| EBITDA | 1.51B | 1.26B | 1.21B | 1.01B | 1.04B | 790.5M | 640.9M | 574.5M | 496.2M | 428.5M | 368.9M | 319.1M | 321.4M | 315.0M | 284.4M | 249.8M | 225.7M | 220.4M |
| Net Income | 1.06B | 887.9M | 845.0M | 679.1M | 744.8M | 581.8M | 427.7M | 377.0M | 263.1M | 222.0M | 192.1M | 181.9M | 187.8M | 178.3M | 161.8M | 141.3M | 122.2M | 116.2M |
| Per Share Data | ||||||||||||||||||
| EPS (diluted) | $13.08 | $10.67 | $10.06 | $8.03 | $8.60 | $6.71 | $4.89 | $4.26 | $2.94 | $2.44 | $2.05 | $1.79 | $1.74 | $3.17 | $2.78 | $2.37 | $2.01 | $1.87 |
| Shares Outstanding (dil.) | 81M | 83M | 84M | 85M | 87M | 87M | 88M | 88M | 90M | 91M | 94M | 102M | 108M | 56M | 58M | 60M | 61M | 62M |
IDEXX Laboratories, Inc. Income Statement — FAQ
IDEXX Laboratories, Inc. (IDXX) income statement over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IDXX's income statement history?
The chart and table above show IDEXX Laboratories, Inc.'s income statement by year and by quarter, including the growth rate.